EmergeX, LLC
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Aug 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches (US 11,660,265) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 1 fee due May 3, 2027The maintenance fee for Stable glucagon peptide formulations (US 9,173,924) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
- 1 fee due Jun 12, 2027The maintenance fee for Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines (US 11,839,683) comes due Jun 12, 2027. Unpaid by Dec 13, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,173,924 | Stable glucagon peptide formulations In force · From the USPTO record | In force | From the USPTO record | |
| US 9,918,932 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines In force · From the USPTO record | In force | From the USPTO record | |
| US 11,058,630 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines In force · From the USPTO record | In force | From the USPTO record | |
| US 11,839,683 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines In force · From the USPTO record | In force | From the USPTO record | |
| US 11,301,747 | System and Method for Facilitating Affective-State-Based Artificial Intelligence In force · High confidence | In force | High confidence | |
| US 11,300,965 | Methods and systems for navigating autonomous and semi-autonomous vehicles In force · From the USPTO record | In force | From the USPTO record | |
| US 11,660,265 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches In force · From the USPTO record | In force | From the USPTO record | |
| US 12,007,783 | Methods and systems for navigating autonomous and semi-autonomous vehicles In force · From the USPTO record | In force | From the USPTO record | |
| US 12,033,672 | Methods and Systems for Generating Interactive Composite Media Assets Comprising Common Objects In force · Low confidence | In force | Low confidence | |
| US 12,287,822 | Methods and Systems for Generating Interactive Composite Media Assets Comprising Common Objects In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 11: 1 patent in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned · 2 no status recorded